Immunosuppressant Switch Cuts Skin Cancer Post-Transplant Renal and Urology News In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival and delayed development of new skin ... |
